Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Battery Passport Industry Research 2025-2035: Minespider, AVL, Siemens, Circulor, and Optel Group Market Shares, Growth Strategies, and Service Offerings

March 3, 2026

$5.34 Bn Railway Testing Market by End Use, Superstructure Testing Equipment, Electrification Testing Equipment, Use Case, Application, and Region – Global Forecast to 2032

March 3, 2026

$20+ Bn Connected Worker Global Market Forecasts 2025-2030 with Zebra Technologies, Honeywell International, Microsoft, and Hexagon Dominating

March 3, 2026

SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments

March 3, 2026

Ride the XRP Wave at Bitrue With a 70,000 XRP Trading Contest

March 3, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » AEON Clinic Introduces Exomind to Treat OCD ADHD PTSD And Other Complex Mental Health Conditions
Press Release

AEON Clinic Introduces Exomind to Treat OCD ADHD PTSD And Other Complex Mental Health Conditions

By News RoomMarch 3, 20262 Mins Read
AEON Clinic Introduces Exomind to Treat OCD ADHD PTSD And Other Complex Mental Health Conditions
Share
Facebook Twitter LinkedIn Pinterest Email

DUBAI, United Arab Emirates, March 03, 2026 (GLOBE NEWSWIRE) — AEON Clinic, a top pioneer in regenerative medicine and opulent healthcare situated at Atlantis the Royal, is happy to present EXOMIND™, an innovative, non-invasive Transcranial Magnetic Stimulation (TMS) system. Intended to transform mental well-being, EXOMIND™ provides a science-led OCD treatment, Anxiety treatment, drug-free alternative for those fighting with ADHD and PTSD, and other complicated neurological illnesses.

EXOMIND™ distinguishes itself in an age when executive tiredness and neurodevelopmental difficulties are becoming more common by addressing the underlying cause of mental health problems: neurological dysregulation. Through local magnetic pulses stimulating underactive neurons, EXOMIND™ promotes neuroplasticity, hence rewiring the brain.

A fresh standard in precision psychiatry usually depending on a one-size-fits-all drug strategy, standard mental health therapies using brain mapping to guarantee that every pulse is delivered to the exact millimeter of the brain needing assistance, AEON Clinic’s EXOMIND™ approach flips this scenario.

According to the AEON Medical Team, EXOMIND™ is a recalibration of the human experience rather than only a medication. “By focusing on the particular neural circuits engaged in focus, anxiety, and repetitive behaviours, we are enabling patients their lives back, free from the sedative side effects of conventional medicine.”

Why Choose EXOMIND™?

  • Rapid results for ADHD, Anxiety and OCD: Improves executive function and lessens the din of unwelcome thoughts.
  • Calms the overactive amygdala to assist patients in processing trauma free of physical symptoms of anxiety; PTSD recovery and gives OCD treatment and Anxiety treatment.
  • Zero downtime: A walk-in, walk-out technique perfectly suited for the hectic lifestyle of busy individuals.
  • Treatments are delivered within the world-class, luxury setting of Atlantis The Royal to guarantee a calm, stress-free recuperation process known as the AEON Advantage.

Merged Longevity

The debut of EXOMIND™ confirms AEON Clinic’s leadership in international longevity research even further. AEON Clinic offers a 360-degree approach to biological and psychological optimization by integrating neurostimulation with the clinic’s own regenerative treatments including IV infusions and hyperbaric oxygen therapy.

As the first clinic in the region affiliated with the American Board of Regenerative Medicine, AEON Clinic continues to redefine the biological clock through evidence-based longevity regimes and bespoke wellness journeys.

To book a private consultation:

Email: [email protected]

Phone: +971 4518 5777

Website: www.theaeonclinic.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/333ca81a-d309-4be2-801a-cb41c45cecf0

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Battery Passport Industry Research 2025-2035: Minespider, AVL, Siemens, Circulor, and Optel Group Market Shares, Growth Strategies, and Service Offerings

$5.34 Bn Railway Testing Market by End Use, Superstructure Testing Equipment, Electrification Testing Equipment, Use Case, Application, and Region – Global Forecast to 2032

$20+ Bn Connected Worker Global Market Forecasts 2025-2030 with Zebra Technologies, Honeywell International, Microsoft, and Hexagon Dominating

SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments

Ride the XRP Wave at Bitrue With a 70,000 XRP Trading Contest

Charles IT, a Connecticut-Based Managed Service Provider Achieves CMMC Level 2 Certification, Positioning Defense Contractors to Meet Looming Federal Compliance Deadlines

From Track to Pitch: Zoomex Teams Up with TGR Haas F1 Team and Emiliano Martínez to Launch Its 2026 Road to the Championship

Multiverse Computing Launches CompactifAI APP, Bringing Offline AI to Edge Devices

Zoomex Announces Strategic Upgrade to Core Trading Infrastructure, Strengthening Execution Standards for 2026

Editors Picks

$5.34 Bn Railway Testing Market by End Use, Superstructure Testing Equipment, Electrification Testing Equipment, Use Case, Application, and Region – Global Forecast to 2032

March 3, 2026

$20+ Bn Connected Worker Global Market Forecasts 2025-2030 with Zebra Technologies, Honeywell International, Microsoft, and Hexagon Dominating

March 3, 2026

SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments

March 3, 2026

Ride the XRP Wave at Bitrue With a 70,000 XRP Trading Contest

March 3, 2026

Latest News

Charles IT, a Connecticut-Based Managed Service Provider Achieves CMMC Level 2 Certification, Positioning Defense Contractors to Meet Looming Federal Compliance Deadlines

March 3, 2026

From Track to Pitch: Zoomex Teams Up with TGR Haas F1 Team and Emiliano Martínez to Launch Its 2026 Road to the Championship

March 3, 2026

Multiverse Computing Launches CompactifAI APP, Bringing Offline AI to Edge Devices

March 3, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version